Moderna (MRNA) PT Raised to $69 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Edward Tenthoff raised the price target on Moderna (NASDAQ: MRNA) to $69.00 (from $63.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
